Medical Research
Research Suggests GLP-1 Drugs May Slow Cancer Spread
Recent research indicates that glucagon-like peptide-1 (GLP-1) weight-loss medications may slow the progression of certain cancers. This study will be presented at the upcoming ASCO Annual Meeting in 2026 in Chicago. Study and Findings Conducted
The Impact of Sitting Habits on Dementia Risk: New Insights
For years, researchers have associated prolonged sitting with increased dementia risk. However, new findings indicate that the type of sedentary behavior might play a more crucial role than previously understood. A study published in the
Unique Genetic Diagnosis Brings Clarity to a Teen’s Health Struggles
At 18, Lucia Adarve had encountered more doctors than most people do in their entire lives. From birth, she faced numerous challenges: missing developmental milestones, experiencing seizures leading to collapses and concussions, and having difficulties
FDA Speeds Up Pancreatic Cancer Drug Approval Process
The FDA is accelerating the approval process for a pancreatic cancer drug called daraxonrasib. Dr. Janette Nesheiwat, a physician specializing in family and emergency medicine, discussed on ‘Fox Report’ how artificial intelligence might assist in
New Treatment Shows Promise for Endometrial Cancer
Merck’s latest investigational drug, sacituzumab tirumotecan (sac-TMT), has displayed promising results in treating endometrial cancer during a Phase 3 clinical trial. The company’s announcement highlighted the drug’s success in achieving its primary endpoints of overall